作者
Yashashwi Pokharel, Fengming Tang, Philip G Jones, Vijay Nambi, Vera A Bittner, Ravi S Hira, Khurram Nasir, Paul S Chan, Thomas M Maddox, William J Oetgen, Paul A Heidenreich, William B Borden, John A Spertus, Laura A Petersen, Christie M Ballantyne, Salim S Virani
发表日期
2017/4/1
期刊
JAMA cardiology
卷号
2
期号
4
页码范围
361-369
出版商
American Medical Association
简介
Importance
The 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline recommends moderate-intensity to high-intensity statin therapy in eligible patients.
Objective
To examine adoption of the 2013 ACC/AHA guideline in US cardiology practices.
Design, Setting, and Participants
Among 161 cardiology practices, trends in the use of moderate-intensity to high-intensity statin and nonstatin lipid-lowering therapy (LLT) were analyzed before (September 1, 2012, to November 1, 2013) and after (February 1, 2014, to April 1, 2015) publication of the 2013 ACC/AHA guideline among 4 mutually exclusive risk groups within the ACC Practice Innovation and Clinical Excellence Registry. Interrupted time series analysis was used to evaluate for differences in trend in use of moderate-intensity to high-intensity statin and nonstatin LLT use in hierarchical logistic regression …
学术搜索中的文章
Y Pokharel, F Tang, PG Jones, V Nambi, VA Bittner… - JAMA cardiology, 2017